Brigid TitgemeierBeingBrigid Functional Nutrition · Transforming Women's Health Using Food as Medicine

The Truth About Hormone Replacement Therapy & the 2002 Women’s Health Initiative Study

10 Sept 2025 · 1 min

Watch on YouTube

1:17

In this video, Brigid Titgemeier explains how the 2002 Women’s Health Initiative (WHI) study reported associations between hormone replacement therapy (HRT) and increased risks of breast cancer, heart disease, stroke, and blood clots, which caused widespread fear and led clinicians to stop recommending HRT. She then presents Dr. Joanne Pinkerton’s critique, highlighting major flaws in the WHI—particularly its broad age range (50‑79, average 63). Pinkerton points out that women under 60 showed very few cardiovascular events and, when they started HRT, experienced lower risks of breast cancer, fractures, overall mortality, and diabetes compared to non‑users. Titgemeier argues that the WHI’s conclusions caused unnecessary harm and that younger women may actually benefit from HRT.

Chapters

The 2002 Women's Health Initiative ended up indicating that there was a association between hormone replacement therapy and an increased risk of breast cancer, heart disease, stroke and blood clots, which sent everyone into high levels of fear. Practitioners stopped recommending hormone replacement therapy. Women stopped asking for hormone replacement therapy because there was a huge concern over the risk of cancer and heart disease. The Women's health initiative, as Dr. Joanne Pinkerton pointed out, ended up being very flawed, and it has created a lot of unnecessary harm over the last few decades, which these experts were there to try to clarify. So she had stated that the Women's Health Initiative, among the many flaws, that it included a wide age gap. It included women between the ages of 50 to 79, with the average age of the woman going through the Women's health initiative being 63. And she highlighted that before the age of 60, that they actually see a very small numbers of heart events, blood clots and stroke. And at the same time, women that are under the age of 60 who start hormone replacement therapy have much lower risk of breast cancer. All fractures, all cancer, all cause mortality and diabetes compared to women who are not taking hormone replacement therapy.